Labiotech.eu

Sophia Genetics artificial intelligence fundraising

News and Trends 13 Sep 2017

Series D Boost will Bring Artificial Intelligence to Diagnostics Worldwide

Sophia Genetics has raised $30M (€25M) in Series D that will be directed to growing and improving its artificial intelligence platform for genetic diagnostics. The Swiss company Sophia Genetics has announced today a new round of funding, led by Balderton Capital, and joined by 360º Capital Partners and existing investors Invoke Capital and Alychlo. The […]

September 13, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Sep 2017

What You Need to Know About the EU’s New Data Protection Law

The EU’s new data protection law is going to have a great impact on companies worldwide, including those involved in clinical trials. Here’s what you have to know and how to act! In May 2018, the European Union’s new data protection law, the General Data Protection Regulation (GDPR), is set to replace the current Data […]

September 13, 2017 - 13 minutesmins - By External Contributor

Infographics 13 Sep 2017

The 10 Most Innovative HIV Treatments to Defeat AIDS

This infographic gathers 10 of the best HIV treatments in Europe’s pipeline that will help doctors worldwide fight against AIDS better than ever before. With an estimated 36.7 million people living with HIV worldwide, the search for an effective treatment that can overcome the fast evolution of the virus is rapidly gaining traction. In Europe, […]

September 13, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 12 Sep 2017

France Invests €15M in Developing a New Generation of Antibiotics

Deinove has received funding from Bpifrance to work on the discovery of the next generation of antibiotics to fight antibiotic-resistant pathogens. The Investments for the Future Program, operated by the French public investment bank Bpifrance, has granted €14.6M to the Antibiotics against Resistant Infectious Germs (AGIR) project, carried out by the Deinove group in collaboration […]

September 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 12 Sep 2017

Shire’s Treatment for Chronic Lung Disease in Premature Infants Fast Tracked by FDA

The FDA has fast tracked Shire’s candidate for chronic lung disease in extremely premature infants from Phase 2 of clinical development. The FDA has fast tracked Shire’s candidate, SHP607, for the treatment of chronic lung disease based on preclinical data, the results of Phase I and II studies so far, and a lack of treatments […]

September 12, 2017 - 1 minutemin - By Alex Dale

News and Trends 12 Sep 2017

Norwegian Biotech Announces Positive Phase I Results for T cell-Stimulating Vaccine

PCI Biotech’s T cell-stimulating vaccine enhances the cellular immune response, supporting it as a candidate for use alongside cancer vaccines. PCI Biotech, based in Oslo, Norway, has seen positive initial results in an ongoing Phase I trial for its firmaVacc technology. The trial is being carried out in 110 healthy subjects, and it aims to […]

September 12, 2017 - 2 minutesmins - By Alex Dale

News and Trends 12 Sep 2017

British Biotech Receives €52M Boost To Beat Antimicrobial Resistance with New Antibiotic

Summit Therapeutics has been awarded the Barda Contract worth up to $62M (€52M) to continue to the development of a new antibiotic for hospital-acquired infections. Summit Therapeutics, a biopharma company operating in the UK and US, has received the Barda Contract, designed to counter public health emergencies. In this case, the money will help to […]

September 12, 2017 - 3 minutesmins - By Alex Dale

News and Trends 12 Sep 2017

French Nanoparticle Therapy Fails to Improve Liver Cancer Treatment in Phase III

Onxeo has announced Phase III results for its nanoparticle chemotherapy Livatag, which failed to improve the outcome for patients with hepatocellular carcinoma compared to other available treatments. The stock of the French oncology specialist Onxeo was halved this morning when it revealed the results of a Phase III trial with its candidate Livatag that failed to […]

September 12, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Sep 2017

French Startup Raises €11M in Series A to Reinvent DNA Synthesis

DNA Script has gathered the support of key international investors to take a new, faster DNA synthesis technology closer to the market. In a Series A round led by Illumina Ventures and joined by Merck Ventures and existing investors Sofinnova Partners, Kurma Partners, and Idinvest Partners, the young French startup DNA Script has raised a total […]

September 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

imfinzi astrazeneca breakthrough designation

News and Trends 11 Sep 2017

UPDATE: AstraZeneca’s Checkpoint Inhibitor Could be a Lung Cancer Blockbuster

UPDATE: 11/09/2017: AstraZeneca has presented impressive results at ESMO that show Imfinzi adding 11 months to patient survival, or decreasing the risk of progression by 48%, in Stage 3 NSCLC. This indication represents a sizable market segment — about half of lung cancer — and Imfinzi’s first-line position could make it a blockbuster. Original Publication: […]

September 11, 2017 - 2 minutesmins - By Evelyn Warner

More News! 11 Sep 2017

Could a Protein in Yeast hold the Secret to Escaping Age-Related Diseases?

Researchers in Basel, Switzerland have identified a protein in yeast that slows protein synthesis, prolonging their lifespan. Gcn4 is a transcription factor that regulates the expression around 10% of the yeast genome. Nutrient restriction and moderate stress extend lifespan and under these conditions, yeast expresses Gcn4 to regulate protein synthesis. The aim is now to find […]

September 11, 2017 - 2 minutesmins - By Alex Dale

Gecko Biomedical Setalum surgical glue CE mark approval

News and Trends 11 Sep 2017

Gecko Biomedical’s Bio-inspired Surgical Glue Gets EU Approval

Gecko Biomedical has received CE Mark for Setalum, a light-activated biocompatible sealant, for its use in vascular reconstruction surgery. The Parisian company Gecko Biomedical has received today marketing approval in Europe for its first product; Setalum is a biocompatible polymer that can be activated on demand with light to give surgeons more control during open […]

September 11, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Series D Boost will Bring Artificial Intelligence to Diagnostics Worldwide

What You Need to Know About the EU’s New Data Protection Law

The 10 Most Innovative HIV Treatments to Defeat AIDS

France Invests €15M in Developing a New Generation of Antibiotics

Shire’s Treatment for Chronic Lung Disease in Premature Infants Fast Tracked by FDA

Norwegian Biotech Announces Positive Phase I Results for T cell-Stimulating Vaccine

British Biotech Receives €52M Boost To Beat Antimicrobial Resistance with New Antibiotic

French Nanoparticle Therapy Fails to Improve Liver Cancer Treatment in Phase III

French Startup Raises €11M in Series A to Reinvent DNA Synthesis

UPDATE: AstraZeneca’s Checkpoint Inhibitor Could be a Lung Cancer Blockbuster

Could a Protein in Yeast hold the Secret to Escaping Age-Related Diseases?

Gecko Biomedical’s Bio-inspired Surgical Glue Gets EU Approval

Subscribe to our newsletter to get the latest biotech news!